The QualityStocks Daily Thursday, January 3rd, 2019

Today's Top 3 StockMarketWatch

CryptoCurrencyWire (SING) +94.48%

QualityStocks (AXIM) +68.13%

StockMarketWatch (OHRP) +61.36%

The QualityStocks Daily Stock List

Flower One Holdings, Inc. (FLOOF)

Street Insider, InvestorsHub, New Cannabis Ventures, Investing News, Dividend Investor, Morningstar, and The Cannabis Investor reported on Flower One Holdings, Inc. (FLOOF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Flower One Holdings, Inc. is the owner of Nevada's largest cannabis cultivation and production facility. The Company works to take advantage of the industry's foremost agricultural technologies, employing unique growing and sustainability practices to cultivate high-quality cannabis at scale for Nevada's growing cannabis market. Flower One Holdings’ shares trade on the OTC Markets Group’s OTCQB. The Company has its corporate office in Toronto, Ontario.

Flower One Holdings’ corporate mission is to build a recognizable international brand. It aims to do so while maintaining an agile approach to customized orders of cannabis flower and cannabis derivatives.

Flower One Holdings has the largest commercial scale greenhouse in the State of Nevada. Flower One is licensed for medical marijuana cultivation and production, and recreational marijuana cultivation and production in Nevada.

Upon being canopied, slated for Q1 2019, the 455,000 square foot facility will be used for cannabis cultivation. It will also be used for the processing, production and high-volume packaging of dry flower, cannabis oils, concentrates and infused products.

When the Company’s greenhouse is totally operational in 2019, along with its indoor facility, it will be able to produce 140,000 pounds (62,500 kilograms) per year. The Company’s state-of-the-art greenhouse and production facility are strategically situated close to the fast-growing, tourism-driven Las Vegas recreational and medical cannabis market.

Today, Flower One Holdings announced that it will begin trading today in the United States on the OTCQB marketplace under the symbol "FLOOF".

Mr. Ken Villazor, Flower One Holdings’ President and Chief Executive Officer, said, "Today's listing on the OTCQB reaffirms our commitment to improving the Company's visibility and exposure in the United States. We believe that trading on OTCQB will further broaden the Company's shareholder base by allowing prospective U.S.-based investors to more readily obtain information and access through a domestic trading platform. Flower One is sharply focused in the U.S. cannabis sector and this listing is vital to our overall growth strategy as a public company."

Flower One Holdings, Inc. (FLOOF), closed Thursday's trading session at $1.07, up 3.06%, on 17,100 volume with 9 trades. The average volume for the last 3 months is 34,192 and the stock's 52-week low/high is $0.88/$1.45.


Thin Film Electronics ASA (TFECY)

OTC Markets, Dividend Investor, Morningstar, Market Screener, The Street, Marketbeat, InvestorsHub, Business Wire, YCharts, Stockwatch, Penny Stock Hub, Current Charts, Street Insider, MarketWatch, TradingView, Stockhouse, Wallet Investor, and Investors Hangout reported previously on Thin Film Electronics ASA (TFECY), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Thin Film Electronics ASA is a worldwide leader in NFC (Near Field Communication) mobile marketing solutions. The Company is enabling the Internet of Everything through its NFC solutions. Thin Film Electronics has its global headquarters in Oslo, Norway; its U.S. headquarters in San Jose, California; and offices in Linköping, Sweden; San Francisco; London; Hamburg; Singapore; and Shanghai. The Company lists on the OTC Markets Group’s OTCQX.

Thin Film Electronics’ mission is to deliver solutions that leverage mobile devices as intelligent agents to help create and connect the Internet of Everything. Moreover, the Company’s mission is to create printed integrated systems using innovative, high-volume processes to deliver scale advantages over conventional electronics.

Thin Film Electronics provides consumer-centered NFC mobile marketing and industrial and supply chain solutions. These include blockchain applications. The Company provides end-to-end support throughout the whole process. This starts with the manufacturing of NFC tags via its cutting-edge, roll-to-roll printed electronics production process, integration support to get the tags on physical objects, and the Company’s CNECT™ cloud-based software platform that captures data and provides actionable insights into consumer behavior and business logistics.

Thin Film Electronics creates printed tags, labels, and systems. These include sensors and wireless communication. The Company offers end-to-end mobile marketing solutions. These solutions feature hardware, label/packaging integration services, and complete cloud-based reporting and analytics.

Its NFC Solutions are optimized for consumer and industrial applications. This includes its OpenSense™ Technology - Dual-ID tag with sealed/opened sensor. It features authentication and refill fraud protection. Its solutions also include SpeedTap™ Technology - Single-ID tag. It features
instant product authentication and targeted marketing and track & trace capabilities.

This past November, Thin Film Electronics announced it received the IDTechEx Technical Development in Manfacturing award in recognition of its pioneering roll-to-roll printed electronics fab in San Jose. Presented as part of the Printed Electronics USA 2018 conference, the IDTechEx Awards recognize company development and success in the field of printed electronics. The Technical Development in Manufacturing award recognizes the most significant development of a manufacturing device, process, or production plant in the industry over the last 24 months.

Thin Film Electronics’ Junction Avenue facility features a 22,000 sq-ft printed electronics factory. This the world’s first production roll-to-roll (R2R) printed electronics line using stainless steel substrates. The fab, designed for an annual production capacity of up to seven billion units, is optimized to enable production of low-cost, mechanically strong devices enabling high-volume applications

Thin Film Electronics ASA (TFECY), closed Thursday's trading session at $0.80, up 0.12%, on 700 volume with 1 trade. The average volume for the last 3 months is 2,258 and the stock's 52-week low/high is $0.79/$3.48.


Invictus MD Strategies Corp. (IVITF)

Awesome Penny Stocks, Wallstreet Online, Investors Hangout, MarketWatch, InvestorsHub, Stockwatch, Market News Updates, Wallet Investor, TradingView, The Venture Report, Market Chameleon, BioSpace, Stockhouse, OTC Markets, CannaBizNetwork, and Barchart reported earlier on Invictus MD Strategies Corp. (IVITF), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Invictus MD Strategies Corp. is a global cannabis company based in White Rock, British Columbia. Invictus offers a selection of products under a wide range of lifestyle brands. The Company and its subsidiaries primarily engage in the investment, acquisition, and development of synergistic businesses in the medical cannabis industry in Canada. Invictus MD Strategies lists on OTC Markets’ OTCQX.

Invictus’ commitment is to providing patients and adult users with high-quality medical-grade cannabis. It represents a strong platform of licensed cannabis producers across Canada. The Company has secured one of the strongest cultivation profiles in Canada, supported by more than 250 acres of production capacity. Through more than 50,000 kgs by 2021. Invictus supports its growers with state-of-the-art production and processing facilities.

Invictus MD Strategies’ portfolio includes Acreage Pharms Ltd. (West-Central Alberta – 100 percent Ownership); AB Laboratories, Inc. (Hamilton, Ontario – 50 percent Ownership); and AB Ventures, Inc. (Hamilton, Ontario - 33.3 percent Ownership). In addition, its portfolio includes Future Harvest (Kelowna, British Columbia - 82.5 percent Ownership).

Last month, Invictus announced that it entered into a non-binding Letter of Intent (LOI) with GTEC Holdings Ltd. for the acquisition by Invictus of all of the issued and outstanding shares in the capital of GTEC in an all-share transaction valued at roughly $100 million, forming Western Canada's largest indoor vertically integrated cannabis companies. The combined entities would provide a vertically integrated cannabis company, centered on producing premium flower and complementary product portfolio, cultivated in purpose-built indoor facilities complemented with first-class genetics.

Mr. George E. Kveton, Invictus MD Strategies’ Chief Executive Officer, said, "We have been pleased with the continued execution of the team and business strategy at GTEC. The dedication to producing a premium product medical and adult-use recreational portfolio for the industry has always been our relentless pursuit. This merger allows for both companies to leverage the combined core competencies to further execute our vision to be at the forefront of the Canadian cannabis industry and beyond."

Invictus MD Strategies Corp. (IVITF), closed Thursday's trading session at $0.6801, up 7.95%, on 180,956 volume with 149 trades. The average volume for the last 3 months is 217,577 and the stock's 52-week low/high is $0.5136/$2.76.


Processa Pharmaceuticals, Inc. (PCSA)

NetworkNewsWire, Stockflare, MarketWatch, Biz Journals, Marketbeat, TradingView, PR Newswire, Stockopedia, Infront Analytics, Stockhouse, Barchart, Dividend Investor, Morningstar, YCharts, InvestorsHub, Simply Wall St, last10k, Biospace, 4-Traders, and Financial Content reported on Processa Pharmaceuticals, Inc. (PCSA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Processa Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company listed on the OTC Markets’ OTCQB. It is developing products to improve the survival and/or quality of life for patients who have high unmet medical need conditions. In October 2017, the Company acquired the assets of Promet Therapeutics, LLC. It assembled a proven regulatory science development team, management team, and Board of Directors. Processa Pharmaceuticals has its corporate headquarters in Hanover, Maryland.

On December 6, 2018, Processa Pharmaceuticals announced that its stock began trading on the OTCQB Market (OTCQB) after successfully up-listing from the OTC Pink Market. Processa’s belief is that its listing on the OTCQB will provide enhanced investor benefits. This includes higher reporting standards, greater access to analyst coverage and news services, and more comprehensive compliance requirements.

The Processa Team are experts in developing drug products from IND enabling studies to NDA submission. The Company’s plan is to have a pipeline of drugs that already have some proof-of-concept clinical data supporting its clinical use in the indication selected and in 2-4 years subsequent to acquisition will either have completed the pivotal study or be ready for a pivotal study and out-licensing.

Processa Pharmaceuticals’ lead product is PCS-499. It will be investigated for the treatment of Necrobiosis Lipoidica, a necrotizing skin condition, caused by a number of pathophysiological changes. PCS-499 represents the first Processa Pharmaceuticals drug that can potentially be used in several unmet medical need conditions. A second unmet medical need under investigation is the use of PCS-499 to treat radiation-related adverse effects in head & neck cancer. For both indications there is no Food and Drug Administration (FDA) approved treatments. Moreover, the current standard of care is not adequate for patients.

Recently, Processa Pharmaceuticals announced that the FDA granted the Company clearance to proceed with a Phase 2 clinical trial of PCS-499 in patients with Necrobiosis Lipoidica (NL) under a recently submitted Investigational New Drug (IND) application. NL is a chronic, disfiguring condition affecting the skin and the tissue under the skin usually on the lower extremities with no presently approved FDA treatments. PCS-499 may provide a solution since PCS-499 and its metabolites affect several biological pathways, a number of which contribute to the pathophysiology associated with NL.

Processa Pharmaceuticals, Inc. (PCSA), closed Thursday's trading session at $3.65, up 4.29%, on 715 volume with 8 trades. The average volume for the last 3 months is 591 and the stock's 52-week low/high is $1.50/$5.125.


MedMen Enterprises, Inc. (MMNFF)

OTC Markets, Penny Stock Hub, GuruFocus, OTC Stock Watch, Stockhouse, 4-Traders, Morningstar, Insider Financial, The Street, Wallmine, TradingView, Barchart, Stockwatch, OTC Stock Picks, New Cannabis Ventures, MarketWatch, Daily Marijuana Observer, Investors Hangout, and Investing News reported on MedMen Enterprises, Inc. (MMNFF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

MedMen Enterprises, Inc. brings expertise and capital to the cannabis industry. The Company is one of the nation’s largest financial supporters of progressive marijuana laws. MedMen Enterprises owns and operates 18 facilities covering the entire vertical from cultivation to manufacturing to retail in three key states - California, Nevada and New York. OTCQX-listed, MedMen Enterprises has its corporate headquarters in Los Angeles, California.

MedMen Enterprises manages class leading retail stores that sell marijuana and marijuana products. MedMen operates a number of dispensaries in the most strategic markets in the nation. It has a fast-growing footprint. This includes expansion plans in other important States as well as Canada.

MedMen has added ground cannabis flower to its product offerings in the State of New York. At present, Company stores in New York offer vaporizer pens, tinctures and gel caps in five different formulations. The addition of ground flower will give its New York medical marijuana patients more product choices in the State’s fast developing market.

MedMen Enterprises has a total of three stores planned for Las Vegas, Nevada. The Company earlier announced its expansion into a fourth key market, Florida, via a proposed acquisition of dispensary and cultivation assets from Treadwell Simpson Partnership and affiliates. MedMen Enterprises has secured prime retail locations with long term leases in Ft. Lauderdale, Miami Beach, West Palm Beach, St. Petersburg and Key West. The Company continues to expand its presence in premier retail districts with high visibility and heavy foot traffic.

MedMen has also acquired a dispensary and cultivation license and related assets from Florida based Treadwell Simpson Partnership and affiliates (Treadwell Nursery). This License permits MedMen to open 30 (and up to 35 if certain conditions are met) medical marijuana dispensaries in Florida and to conduct cultivation, delivery and manufacturing operations in the State. As part of the transaction, MedMen Enterprises acquired Treadwell Nursery’s cultivation facility located on five acres near Orlando.

Moreover, Captor Capital Corp. has signed a definitive agreement to sell the retail operations and license for a dispensary location in Santa Ana, California, via an all-stock transaction with MedMen Enterprises valued at roughly US$16 million. The store is now MedMen branded and managed. Upon closing, MedMen will issue about 3,740,228 Class B Subordinate Voting shares to Captor Capital. At current market price, the Agreement transaction is valued at US$16,229,567. The final purchase price is subject to adjustment for accrued liabilities at the time of closing.

MedMen Enterprises, Inc. (MMNFF), closed Thursday's trading session at $3.40, up 2.90%, on 1,186,066 volume with 1,923 trades. The average volume for the last 3 months is 1,957,811 and the stock's 52-week low/high is $2.53/$7.57.


Chesapeake Gold Corp. (CHPGF)

Stock Orange, 24hgold, Gold Stock Data, Penny Stock Hub, Capital Cube, Small Cap Network, Barchart, Investor Intel, Metals Channel, The Street, Stockhouse, Wallmine, YCharts, Mining Stock Valuator, Research Pool, Equities, OTC Markets, Silicon Investor, GuruFocus, Northern Miner, MarketWatch, StockInvest, Wallet Investor, Market Screener, Morningstar, Investors Hub, 4-Traders, and Investors Hangout reported on Chesapeake Gold Corp. (CHPGF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Chesapeake Gold Corp. concentrates on the exploration and development of precious metals projects in North America. The Company’s management and technical team have an excellent track record. This team, with Francisco Gold Corp., discovered El Sauzal and Marlin, which are two Goldcorp, Inc. mines in Mexico and Guatemala. Chesapeake Gold’s shares trade on the OTC Markets Group’s OTCQX. The Company is based in Vancouver, British Columbia.

Chesapeake Gold's major project is its 100 percent owned Metates gold deposit This project is in Durango state, Mexico. Metates is one of the largest undeveloped gold and silver projects in the world.

Independent Mining Consultants reported NI 43-101 (National Instrument 43-101) proven and probable reserves of 18.5 million ounces of gold, 526 million ounces of silver, and 4.2 billion pounds of zinc. The metal prices assumed for the reserves are $1,200 per ounce gold and $25 for silver per ounce at a cutoff grade of 0.35 g/t gold equivalent.

Metates has the option to be an initial 30,000 tpd or 60,000 tpd mine that expands to full nameplate capacity. A pre-feasibility study (PFS) by M3 Engineering indicates at the Phase 2 throughput rate of 120,000 tpd, annual production over 25 years would be 659,000 ounces of gold, 16 million ounces of silver and 143 million pounds of zinc at a gold equivalent cash cost of $490 per ounce, net zinc credits.

Chesapeake Gold’s Mexico properties also include Yarely, La Gitana, La Cecilia, and Tatatila. Yarely is an emerging diversified camp and drilling discovered a large porphyry system. The Company’s U.S. property is Talapoosa. Talapoosa has an open pit resource of 1.2 million ozs of gold and 16 million ozs silver with excellent exploration upside. Chesapeake’s Guatemala property is El Escorpion.

This past June, Chesapeake Gold provided an update on the results of the Phase 1 drilling program at the Company’s regional Yarely Project in Sinaloa State, Mexico. Yarely covers 72,000 hectares. It is strategically positioned 10 kilometers from a paved highway and within 25 kilometers of the proposed Metates plant site.

P. Randy Reifel, stated, "Although early stage, the Phase 1 drill campaign has confirmed that Yarely has the potential to be a diversified mineralized camp with district scale prospects. Drilling discovered a blind porphyry system from the geophysical survey at Loretos. A high grade silver-gold vein field and ore grade zinc-gold skarn-hosted mineralization have been identified at Central and Lucy. The geological and geophysical work to date suggests Yarely could host several porphyry type targets which would be the first known in this region of the country.”

Chesapeake Gold Corp. (CHPGF), closed Thursday's trading session at $1.51475, up 5.36%, on 4,855 volume with 13 trades. The average volume for the last 3 months is 8,883 and the stock's 52-week low/high is $1.10/$2.94.


AXIM Biotechnologies, Inc. (AXIM)

TopPennyStockMovers, CFN Media Group, Promotion Stock Secrets, and SmallCapVoice reported previously on AXIM Biotechnologies, Inc. (AXIM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

AXIM Biotechnologies, Inc. is a biotechnology company centering on the research, development, and production of cannabis-based pharmaceutical, nutraceutical, and cosmetic products. The Company discovers and brings to market unique solutions through research and development (R&D), strategic partnerships, and acquisitions through setting the green standard in the industrial hemp industry. Medical Marijuana, Inc. is a major investor in AXIM. OTCQB-listed, AXIM Biotechnologies is based in New York, New York.

AXIM’s concentration is on innovative proprietary delivery mechanisms for the introduction of cannabinoids and finding solutions for conditions for which there is currently no effective treatment. The Company is advancing its patented controlled-release cannabinoid gum in studies encompassing a number of indications. AXIM’s flagship CanChew Plus® contains 10mg of cannabidiol (CBD) obtained from industrial hemp plants.

AXIM Biotechnologies’ pipeline of Intellectual Property (IP) protected cannabinoid-based products additionally include MedChew Rx™. This THC/CBD cannabinoid controlled-release chewing gum is to address pain and muscle spasticity in multiple sclerosis (MS) patients. This pioneering invention is on path to be fully registered by the EMA and the Food and Drug Administration (FDA) by the end of 2017. It is the world’s first patented cannabinoid controlled-release chewing gum.

The Company’s products also include RENECANN™ - the world’s first cannabigerol (CBG)-based skincare product line. Furthermore, its products include ORAXIMAX™ - the world’s first CBG-based oral care product line; Suppocann™ - a suppository cannabinoid-release product for GI conditions including IBD, IBS and Crohn’s disease; and Ophthocann™ and Cannbleph™ - cannabinoid-based products for the lessening of intraocular pressure and for the relief of conjunctivitis.

AXIM® Biotechnologies earlier entered clinical trials at Wageningen University in the Netherlands for the treatment of irritable bowel syndrome (IBS) with AXIM's CanChew Plus® cannabidiol (CBD) gum. AXIM announced that it received approval from the Medical Ethical Committee (METC) at Wageningen University for the trial using controlled-release hemp oil CBD chewing gum with patients suffering from IBS.

AXIM Biotechnologies announced recently that it filed with the United States Patent and Trademark Office (USPTO) for U.S. Application Serial Number 62/410,469. This is a patent of invention, which involves a chewing gum composition with controlled release of cannabinoids and opioid agonists and/or antagonists for addiction and/or dependence treatment. In addition, the chewing gum may be used for the treatment of chronic pain.

AXIM Biotechnologies has entered into a Clinical Study Agreement (CSA) with the University of British Columbia to start a clinical trial with its CanChew Plus® cannabidiol (CBD) chewing gum product to treat drug-induced psychosis in adult patients. The University will work with Health Canada and its own ethics board to design the trial that will take place at the University of British Columbia, and will demonstrate the efficacy of AXIM Biotechnologies’ chewing gum product composed of 50mg CBD to treat drug-related psychosis.

AXIM’S IP portfolio now includes two fully issued patents – one patent permitting the use of CBD (cannabidiol) in controlled-release, functional chewing gum, and another patent for chewing gum containing natural and synthetic cannabinoids for the treatment of pain, and 15 patent applications in different stages of approval. AXIM now has registered 18 trademarks nationally and worldwide, with five more trademark applications pending all founded on products formulated and developed by AXIM Biotechnologies.

AXIM Biotechnologies, Inc. (AXIM), closed Thursday's trading session at $1.53, up 68.13%, on 491,245 volume with 687 trades. The average volume for the last 3 months is 78,003 and the stock's 52-week low/high is $0.46/$10.29.


Leatt Corp. (LEAT)

Nebula Stocks, TopPennyStockMovers, and SmallCapVoice reported previously on Leatt Corp. (LEAT), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Leatt Corp. is a worldwide developer, marketer, and distributor of personal protective equipment for all kinds of sport, especially extreme high-velocity sports. Known for the invention of the first-of-its kind Leatt-brace®, Leatt’s range includes helmets, body protection, hydration packs, and gloves. This includes a new range of apparel unveiled in its 2017 product line. Also, other patents and products are undergoing development. Leatt is based in Durbanville, South Africa. The Company’s USA Distribution Office is in Santa Clarita, California.

Leatt has warehouses and the distribution office in Santa Clarita for the North American Market, New Zealand, and an international network of distributors. The Company’s primary area of emphasis is the prevention of neck injuries in persons wearing a crash helmet, for whatever purpose.

The Leatt-Brace® is an award-winning neck brace system. It is considered the gold standard for neck protection for any individual wearing a crash helmet as a form of protection. The design of it is for participants in extreme sports or riding motorcycles, bicycles, mountain bicycles, all-terrain vehicles, snowmobiles, and other vehicles.

Leatt has expanded its Motocross/Off-Road Range of products for 2017. The new portfolio adds a broad assortment of apparel designs, as well as high-performance protection gear, including new helmets. The new launch follows the Company’s launch of new bicycling products into new, wide-ranging consumer markets.

Last week, Leatt announced its financial results for Q2 and six months ended June 30, 2017. For the three months ended June 30, 2017, revenues were $3.5 million, with a net loss of $221,063, or $0.04 per share. This is in comparison to revenues of $3.7 million, with a net loss of $11,456, or $0.00 per share, for the 2016 Q2. For the six months ended June 30, 2017, revenues were $9.3 million, with net income of $50,897, or $0.01 per share. This is in comparison to revenues of $8.5 million, with net income of $101,524, or $0.02 per share, for the first half of 2016.

Mr. Sean Macdonald, Leatt Chief Executive Officer, said, "We expect to ship the 2018 product line to customers globally during the second half of 2017. Our new line includes multiple new and refined Bike and Off-road Motorcycle products that continue to enable riders at all levels to push themselves further with the confidence provided by exceptional innovative protective gear. We look forward to presenting the new Bike range at the upcoming Eurobike exhibition in Germany from August 30 – September 2.”

Leatt Corp. (LEAT), closed Thursday's trading session at $2.45, up 11.36%, on 44,200 volume with 15 trades. The average volume for the last 3 months is 2,998 and the stock's 52-week low/high is $0.67/$3.29.


Lion One Metals Limited (LOMLF)

Stock Twits, Investors Hub, Top Stocks, Barchart, Stockhouse, OTC Markets, Junior Mining Network, MarketWatch, Morningstar, Canadian Mining Report, ‎Investor Ideas, StreetWise Reports, TradingView, Mining Atlas, and Stock World reported earlier on Lion One Metals Limited (LOMLF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Lion One Metals Limited concentrates on advancing to production at its 100 percent owned and fully permitted high grade underground Tuvatu Gold Project. Tuvatu is located on the island of Viti Levu in the Republic of Fiji. Tuvatu is the largest undeveloped gold project in Fiji. In addition, it is one of the highest-grade gold projects anywhere in the world.

A mineral exploration and development company Lion One Metals has its corporate office in Vancouver, British Columbia. The Company also has offices in Fremantle, Australia and in Waimalika, Nadi, Republic of Fiji.

Lion One Metals is focused on cost effective and environmentally responsible construction, development, and advancement of Tuvatu towards production. This is tied with exploration of its district-scale license areas encompassing the highly prospective and underexplored Navilawa volcano. The Company is advancing Tuvatu as a near-term production opportunity with exploration upside in the southwest Pacific Ring of Fire.

Lion One Metals has modeled Tuvatu for exploration after regional giants in the low sulphidation family of high grade epithermal gold deposits. This includes Porgera and Lihir in Papua New Guinea, and Vatukoula in Fiji that boast production of more than 35 million ounces of gold in similar alkaline volcanic settings.

Lion One Metals is focused on building production of 100,000 oz. per year over 10 years. The Company holds a 200 km² exploration license package covering the entire Navilawa volcano, with the Tuvatu mining lease at its center.

The independent Tuvatu NI 43-101 PEA technical report by Mr. Ian Taylor, BSc (Hons) MAusIMM (QP) dated June 1, 2015 envisions a low cost underground gold mining operation producing 352,931 ounces of gold over 7 years at head grades of 11.30 g/t Au, and cash costs of US$567 per ounce with all-in sustaining cost (AISC) of US$779 per ounce. Lion One Metals has not based a production decision on a Feasibility Study (FS) of mineral reserves demonstrating economic and technical viability. Therefore, there is increased uncertainty and economic and technical risks associated.

Lion One Metals Limited (LOMLF), closed Thursday's trading session at $0.31094, up 4.38%, on 10,700 volume with 4 trades. The average volume for the last 3 months is 5,717 and the stock's 52-week low/high is $0.2926/$0.615.


Lucara Diamond Corp. (LUCRF)

InvestorPoint, Penny Stock Tweets, Dividend Investor, Mining Feeds, Barchart, Marketbeat, ProInvestor, Insider Financial, Stockhouse, CapitalCube, MarketWatch, The Street, 4-Traders, Investors Hangout, Stockwatch, Wallmine, and InvestorsHub reported earlier on Lucara Diamond Corp. (LUCRF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Lucara Diamond Corp. is a diamond mining company engaging in the acquisition, exploration, development, and operation of diamond properties in Africa. The Company is a foremost independent producer of large exceptional quality Type IIa diamonds from its 100 percent owned Karowe Mine in Botswana. Lucara Diamond is a member of the Lundin Group of Companies and the Company is based in Vancouver, British Columbia.

The Karowe Diamond Mine in Botswana is one of world’s leading producers of large, Type IIA diamonds in excess of 10.8 carats. This includes the historic 1,109 carat Lesedi La Rona (second largest gem diamond ever recovered) and the 813 carat Constellation (sold for a record US$63.1 million). A PFS is taking place on Karowe underground with the potential to extend the mine-life to 2036.

Lucara Diamond also has its 100 percent owned Clara Diamond Solutions Corp. This is a secure, digital sales platform. It utilizes proprietary analytics together with cloud and blockchain technologies to modernize the existing diamond supply chain, boosting efficiencies, unlocking value and ensuring diamond origin from mine to finger.

Historically, Lucara Diamond has held Regular Stone Tenders (RSTs) and Exceptional Stone Tenders (ESTs). RSTs represent most of the Company’s run of mine production, held approximately four times annually.

Clara Diamond Solutions, Lucara’s 100 percent owned subsidiary, entered into a Collaboration Agreement in 2018 with Sarine Technologies Ltd., the world's leading developer of technologies for the diamond industry. Clara will be the exclusive, global customer for customized interfaces and versions of Sarine Technologies' Galaxy® inclusion mapping technology and its Advisor® optimal rough planning for use with Clara's 100 percent owned, proprietary digital diamond sales platform.

Clara Diamond Solutions uses proprietary analytics together with the most contemporary cloud and blockchain technologies to sell diamonds individually, based on polished demand. With this exclusive collaboration agreement with Sarine Technologies, selected diamonds recovered at a mine site will undergo Galaxy® inclusion mapping, creating a digital fingerprint, which will be uploaded to the Clara platform.

Lucara Diamond Corp. (LUCRF), closed Thursday's trading session at $1.0425, down 1.53%, on 53,771 volume with 28 trades. The average volume for the last 3 months is 59,008 and the stock's 52-week low/high is $1.009/$2.325.


Thunder Energies Corporation (TNRG)

InvestorPlace, The Silicon Review, InvestorsHub, Emerging Growth, Penny Stock Tweets, Penny Stock Hub, ResearchPool, Capital Cube, The Stock Radio, Marketbeat, WalletInvestor, Morningstar, YCharts, The Street, Stockwatch and Market Exclusive reported earlier on Thunder Energies Corporation (TNRG), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Thunder Energies Corporation focuses on the manufacture, sale, and service of varied technologies in the United States. The Company formerly went by the name Thunder Fusion Corporation. It changed its name to Thunder Energies Corporation in May of 2014. Thunder Energies is headquartered in Tarpon Springs, Florida. The Company lists on the OTC Markets.

Thunder Energies markets its technologies through three divisions. These are Nuclear Instruments, Optical Instruments, and Combustion Equipment. Concerning the Division of Nuclear Equipment, the production, promotion, sale and service of the Santilli Thermal Neutron Source is founded on a novel synthesis of the neutron from a hydrogen gas (global patent pending).

Regarding the Division of Optical Equipment, its focus is the production, promotion, sale and service of pairs of Galileo telescopes with convex lenses to detect matter-galaxies & Santilli telescopes with concave lenses to detect antimatter-galaxies (global patent pending).

Pertaining to the Division of Combustion Equipment, its emphasis is the production, promotion, sale and service of the novel HyperFurnace, which achieves the total combustion of fossil fuels and an enhanced energy output (patented and global patents pending).

Dr. Ruggero M. Santilli, Chief Executive Officer and Chief Scientist of Thunder Energies announced in May of 2018 new advances for the model of Directional Neutron Source developed in the U.S. and tested in nuclear facilities in Europe for the detection in airports of nuclear material that may be concealed in suitcases, the detection and concentration of precious metals in mining operations, varied military uses, and other applications.

Recently, Thunder Energies announced that its Division of Combustion is successfully continuing the development of the new chemical species of gas called MagneHydrogen. Thunder Energies has secured the required domain names, has applied for available trademark protections and is finalizing engineering schematics for the initial production of MagneHydrogen, separated from commercially available MagneGas through standard Pressure Swing Absorption equipment.

In addition, recently, Dr. Ruggero Santilli announced that the Company filed an S1 registration statement for a 24 month, 3 million dollar investment from GHS Investments. This is for the hiring of qualified technicians and salespersons and the development of corporate pioneering neutron, combustion and optical technologies.

Dr. Santilli stated, "Following 3 years of searching for all available possibilities of funding our new cutting-edge technologies, the Company concluded that funding via an S1 Registration is the most recommendable. After numerous negotiations with various funding groups, I am pleased to announce the above filing of the S1 Registration for funds from GHS Investments that are the most favorable that we were able to identify. This completes the report of our effort for the funding of Thunder Energies and we shall wait for a response from the SEC."

Thunder Energies Corporation (TNRG), closed Thursday's trading session at $0.0042, down 6.67%, on 1,863,534 volume with 31 trades. The average volume for the last 3 months is 3,025,529 and the stock's 52-week low/high is $0.0035/$0.30.


Centenera Mining Corporation (CTMIF)

Investor Place, Investing News, Stockhouse, MarketWatch, 4-Traders, Junior Mining Network, The Subway Trader, Streetwise Reports, Wallet Investor, Gold Stock Data, and The Wolf Trader reported previously on Centenera Mining Corporation (CTMIF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Centenera Mining Corporation focuses 100 percent on mineral resource assets in Argentina. Centenera Mining has a diverse portfolio of assets in Argentina.  In 2018, the Company centered its  exploration activities on drill-testing its flagship Esperanza copper-gold project. A mineral resource company, Centenera Mining is headquartered in Vancouver, British Columbia.

Centenera’s other assets include the El Quemado lithium pegmatite project in Salta Province and the Organullo gold project. The Organullo project has about 8,000 meters of historical drilling and assay results. Organullo has a geological target range from 19.8 million tonnes grading at 0.94 g/t gold (600,000 ounces) to 31.6 million tonnes grading 0.92 g/t gold (940,000 ounces) using a 0.5 g/t gold cut-off-grade. However, insufficient exploration and geological modeling has taken place to define a mineral resource and the Company notes that it is uncertain if further exploration will result in the delineation of a mineral resource.

Centenera Mining’s project pipeline also includes the Crosby Project, the El Penon Project, the aforementioned El Quemado project, the Mina Angela Project, and the Trigal Project.

The Esperanza Project (acquired in 2017) has existing infrastructure nearby. The Project has a Copper-Gold Porphyry System. Centenera Mining has an option to earn 100 percent interest for cash payments of US$2.3M over 6 years and the issuance of US$0.5M CT stock. The flagship Esperanza Cu-Au Project in San Juan Province is subject to a 2 percent Net Smelter Return (NSR) (right to buy 0.5 percent for US$1M cash).

In October 2018, Centenera Mining announced that it entered into a property option agreement with Yamana Gold, Inc. Yamana, by way of a subsidiary, was granted an option to acquire an initial 70 percent interest in the Company’s Organullo Gold Project in Salta Province, northwestern Argentina.

With this agreement, Yamana Gold may exercise the Option by the preparation and delivery of a Pre-Feasibility Study (PFS) prepared in accordance with National Instrument 43-101 Standards of Disclosure for Mineral Projects (NI 43-101) that reports an aggregate Measured and Indicated Mineral Resource of a minimum of 1,000,000 gold-equivalent ounces by the 6th anniversary of the effective date of the Agreement; completion of property-related expenditures of a minimum of US $5,000,000 in the aggregate; and cash payments of US $1,250,000 in the aggregate.

Centenera Mining Corporation (CTMIF), closed Thursday's trading session at $0.0308, down 23.00%, on 11,000 volume with 3 trades. The average volume for the last 3 months is 10,041 and the stock's 52-week low/high is $0.00812/$0.1684.


Rhino Resource Partners LP (RHNO)

Zacks, Annual Reports, TopPennyStockMovers, Marketbeat, 4-Traders, Dividend Channel, Wall Street Mover, PCG Advisory, and Simply Wall St reported previously on Rhino Resource Partners LP (RHNO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Rhino Resource Partners LP is a diversified energy limited partnership. The Company centers on coal and energy related assets and activities. This includes energy infrastructure investments. Rhino is a diversified energy MLP (Master Limited Partnership). It produces coal in numerous basins in the United States. OTCQB-listed, Rhino Resource Partners is based in Lexington, Kentucky.

Rhino produces metallurgical and steam coal in a variety of basins throughout the United States and also leases coal. The Company’s strategy is to acquire coal reserves and properties with relatively long lives and that could undergo development with low risk at a reasonable cost.

Rhino Resource Partners produces steam coal used to produce electricity and metallurgical coal used in the steel-making process. The Company also manages and leases coal properties and collects royalties from such management and leasing activities. Furthermore, Rhino has oil and gas investments in the Cana Woodford region, which provides added cash flows to its business.

Rhino (via acquisitions and other coal lease transactions) has considerably increased its proven and probable coal reserves and non-reserve coal deposits. Moreover, it has successfully grown its coal production through internal development projects.

This past November, Rhino Resource Partners announced its financial and operating results for the quarter ended September 30, 2018. For the quarter, the Partnership reported a net loss of $4.5 million and Adjusted EBITDA of $4.2 million, versus net income of $1.7 million and Adjusted EBITDA of $7.9 million in the third quarter of 2017.

Diluted net loss per common unit was $0.40 for the quarter versus diluted net loss per common unit of zero for Q3 of 2017. Total revenues for the quarter were $72.6 million, with coal sales generating $71.9 million of the total, versus total revenues of $56.7 million and coal revenues of $56.3 million in the third quarter of 2017.

In Central Appalachia, roughly 72 percent of its full-year 2019 thermal and met coal production has been contracted at increased prices versus 2018. The Company’s Pennyrile, Castle Valley and Hopedale operations are substantially sold out for 2019 at prices that are above Rhino’s 2018 levels. Additionally, Rhino has executed long-term contracts with different utility customers for thermal coal for 2020 at Pennyrile and Castle Valley.

Rhino Resource Partners LP (RHNO), closed Thursday's trading session at $1.00, even for the day, on 50 volume with 1 trade. The average volume for the last 3 months is 767 and the stock's 52-week low/high is $0.80/$3.66.


Pura Naturals, Inc. (PNAT)

Stockwatch, Clay Trader, Insider Financial, Marketwired, OTC Markets, WhaleWisdon, YCharts, Spotlight Growth, Tip Ranks, Dividend Investor, and MarketWatch reported on Pura Naturals, Inc. (PNAT), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Pura Naturals, Inc. is working to deliver a purer clean by way of its innovative BeBetter Foam®. The Company is the manufacturer of unique foam cleaning products for the home. It has its proprietary foam technology, which absorbs grease and grime like a magnet. It does so without harsh chemicals and harboring of bacteria found within traditional household cleaning products and sponges. Pura Naturals is based in Lake Forest, California.

The Company focuses on plant-based products made from renewable resources with no petroleum by-products. Its product portfolio includes Health & Beauty products, including facial pads, exfoliating soap-infused body bars, soap-infused sponges, and soap-infused gentle cleansing pads for babies.

Kitchen & Household products include sponges, soap-infused sponges, non-scratch scrubbers, and non-scratch scrubbers (soap-infused). Pura Naturals’ household cleaning products deliver a unique soap infusion. The ground-breaking foam absorbs grease while repelling water and inhibiting bacteria growth and odors.

Pura Naturals also has its Pura Naturals Marine. The specific design of its marine foam is to handle petroleum base contaminations. It is approved for use by the Environmental Protection Agency (EPA). Marine products include all-purpose sorbent Spill Pads, bilge sorbent Bilge Booms, Spill Bibs (fuel spill prevention), soap-infused personal cleaning bars, and soap-infused galley sponges.

The Pura Marine division centers on developing solutions employing AirTech Foam technologies and allied products directed towards oil spill prevention and remediation in waterways. This division is pursuing business in the trucking and oil sectors. Additionally, Pura Naturals has its all-natural cleaning solution, Pura Pro Bio-Degreaser. This product is a strong citrus based, multi-use cleaner.

Pura also has its new line of health and beauty products. These products will be infused with Cannabidiol (CBD) derived from hemp and hemp seed oils.

In December, Pura Naturals announced that the Grease Beast products went live on Mr. Robert Doherty, Chief Executive officer of Pura Naturals, stated on December 12, 2018, "We have been live on for only a few days, and orders are flowing. This is a solid moment for Pura Naturals. Given the talent we have brought into the Company and the breadth of the achievements thus far, we expect a very strong 2019 for the Grease Beast product line."

Pura Naturals, Inc. (PNAT), closed Thursday's trading session at $0.0047, up 34.29%, on 12,564,869 volume with 216 trades. The average volume for the last 3 months is 6,829,804 and the stock's 52-week low/high is $0.0015/$0.34.


The QualityStocks Company Corner

Cyberfort Software, Inc. (CYBF)

The QualityStocks Daily Newsletter would like to spotlight Cyberfort Software, Inc. (OTC: CYBF).

In 2016, cybersecurity company Cyberfort Software (OTC: CYBF) acquired Vivio, a pioneering ad-blocking application. To view the full article, visit:

Cyberfort Software, Inc. (CYBF) is a cybersecurity technology company specializing in the acquisition and development of security software, content filtering, and ad blocking technology. Headquartered in San Francisco, California, Cyberfort Software is actively dealing with various cyber threats through the development of innovative protection technologies designed for mobile, personal and business tech devices across multiple platforms.

Committed to the idea that everyone – from individuals to global corporations – should be able to enjoy a digital future free of malicious attacks robbing them of privacy and security, Cyberfort is working to strengthen its portfolio of cybersecurity IPs and stay one step ahead of cyberthreats. The growing plethora of tech devices enveloping everyday life opens the door to increasing cyberattacks through a stunning array of sophisticated cyberthreats. Protecting organizations and individuals with proactive security postures and protective measures is a key component of Cyberfort’s strategy to develop cybersecurity solutions that are smart, simple and efficient.

The company’s 2016 purchase of Vivio, a provider of pioneering AI content filtering and software protection, underscores Cyberfort’s commitment to cybersecurity. Vivio, an iOS 10 ad blocking app, currently serves over 10,000 unique users across iPhone, iPad and Mac. Vivio makes web browsing better, faster and more satisfying by blocking ads and reducing data usage, which also helps save battery life. Continuous ad blocking rule updates are delivered via an Intellectual Property Cloud-based autonomous engine with ad blocking tracker and malware detection filters.

Cyberfort recently signed a letter of intent to acquire Just Content Software which includes the Just Content app, software and underlying source code. Just Content is an efficacious and multi-functional ad blocking app that safeguards families and businesses with proprietary “Home Safe Filter” and “Business Filter” products. The Just Content app is available on iTunes and protects against unsafe links, adult content, phishing sites and inflammatory hate speech found on the internet, among other potential backdoor attacks and cyberthreats. A due diligence review is underway and a final determination regarding this acquisition is anticipated within weeks.

“Cyberfort aims to become a leader in developing cutting edge ad-blocking protective software that keeps the internet safe for families and business, which in our highly technological and immediate information-access society is a significant concern. Acquiring Just Content furthers our commitment to provide the best and most effective ad-blocking software in the marketplace,” says Cyberfort CEO Daniel Cattlin.

Favorable government regulations promoting tightened web security is a major factor driving adoption of web content filtering solution along with the public’s growing desire to better manage network bandwidth consumption and protect their online security and privacy. Cyberfort’s objective is to protect the data and integrity of personal and business computing assets and defend those assets against any threat or attack. The company’s software also offers symbiotic ad-blocking capabilities to complement its cyber defense effectiveness.

As Cyberfort continues to innovate, the Vivio team intends to leverage the current user base as a sandbox to test and optimize future incremental developments targeting an enterprise suite of tools that can be integrated into sector specific areas of growth. Key areas of focus include mobile device management, bring your own device (“BYOD”), mobile app management and secure mobile browser.

The Cyberfort leadership team is headlined by Cattlin, who offers a new age perspective to the business with expertise in project and asset management and a background in corporate finance. Cattlin brings both the operational and financial understanding to take companies from start-up and early development to expansion and capital growth within a public environment.

Chief Technology Officer Tomas Mistrik helped his team deliver a variety of technological products including the Vivio ad-blocking app for iOS 10 and the Silicon Valley-based Synergykit platform for mobile developers.

Technology Development Manager Krishna Kumar brings more than 10 years of experience in the Information Technology industry where he provided powerful security and ad-blocking measures for companies such as CSC and PayPal India.

Senior Advisor Harish Doddala brings nine years of product management and software engineering experience, delivering results for Cisco, VMware, Oracle, IBM and Siemens.

Cyberfort Software, Inc. (OTC: CYBF), closed the day's trading session at $0.38, up 31.03%, on 4,221 volume with 5 trades. The average volume for the last 3 months is 15,474 and the stock's 52-week low/high is $0.051/$69.00.

Recent News


Canopy Rivers Inc. (TSX.V: RIV)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV).

Canopy Rivers Inc. (TSXV: RIV) today announced that it has retained Hybrid Financial Ltd. (“Hybrid”), a marketing and retail distribution services company, to provide certain investor relations services. “We are confident that Hybrid will help us increase market awareness and further engage with the investment community,” said Daniel Pearlstein, EVP, Strategy at Canopy Rivers.

Canopy Rivers Inc. (TSX.V: RIV) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a premiere retail cannabis distributor that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Canada’s largest private liquor retailer, Solo Liquor, who collectively have more than 50 years of regulated substance retail experience. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy as “Solo Growth Corp.”
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (TSX.V: RIV), closed the day's trading session at $3.35, up 5.68%, on 295,873 volume with 531 trades. The average volume for the last 3 months is 441,379 and the stock's 52-week low/high is $2.40/$11.82.

Recent News


SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint, Inc. (OTCQB: SING), a fully reporting technology company providing mobile payments, blockchain solutions and ancillary cannabis services, sees the recent passage and signing of the 2018 Farm Bill as a game changer for its subsidiary and its future growth plans. In a video discussion ranging from which CBD-infused product is topping the sales chart at to negotiations underway for new acquisitions, SinglePoint President Wil Ralston and CEO Greg Lambrecht share their thoughts on the impact of the 2018 Farm Bill as it relates to the hemp-derived cannabidiol (CBD) space (

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0282, up 94.48%, on 56,743,778 volume with 1,634 trades. The average volume for the last 3 months is 4,547,571 and the stock's 52-week low/high is $0.0106/$0.103.

Recent News


VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) was featured today in a report from CannabisNewsWire. As calls for marijuana legalization sweep across the U.S., many companies are gearing up to provide yet another way to get your high, by sipping marijuana. Cannabis-infused drinks are poised to be a big thing in 2019 and beyond if the undertones surrounding the cannabis industry are to be believed.

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed the day's trading session at $0.60, up 6.19%, on 409,006 volume with 155 trades. The average volume for the last 3 months is 389,653 and the stock's 52-week low/high is $0.413/$3.29.

Recent News


Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF).

Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) ("Sproutly" or the "Company") is pleased to announce it has retained Hybrid Financial Ltd. ("Hybrid") to provide marketing and investor relations services, pursuant to an agreement (the "Agreement") and commenced marketing services on January 2, 2019. Hybrid has been engaged to heighten market awareness and brand awareness for Sproutly and to broaden the Company's reach with investors. Also today, NetworkNewsWire released a report on the company detailing how, as worldwide prohibition of cannabis eases, restrictions on scientific research into cannabinoids are loosening as well, allowing innovative companies like Sproutly Canada to fully emerge.

Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.


Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTCQB: SRUTF), closed the day's trading session at $0.297, up 0.75%, on 214,994 volume with 116 trades. The average volume for the last 3 months is 213,722 and the stock's 52-week low/high is $0.189/$1.875.

Recent News


First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF).

First Cobalt (TSX.V: FCC) (OTCQX: FTSSF) (ASX: FCC), a pure-play cobalt company whose flagship asset is the Iron Creek Cobalt Project located in Idaho, is focused on creating a North American cobalt supply chain to serve the mounting need for the metal. To view the full article, visit:

First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.

First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.

The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance.

First Cobalt Corp. (FTSSF), closed the day's trading session at $0.1366, up 5.08%, on 97,771 volume with 19 trades. The average volume for the last 3 months is 197,597 and the stock's 52-week low/high is $0.1143/$1.289.

Recent News


Pacific Software, Inc. (PFSF)

The QualityStocks Daily Newsletter would like to spotlight Pacific Software, Inc. (PFSF).

Pacific Software, Inc. (OTC: PFSF) (“Pacific Software” or “the Company”), an emerging development technology corporation positioned for investments, mergers and acquisitions of software technologies and platforms, today announces that its BOAPIN e-commerce trade platform will be ready to register new buyers and sellers within the first quarter of 2019.

Pacific Software, Inc. (PFSF) is focused on the design, development, and distribution of Hyperledger blockchain technology solutions for application to the specific needs of agriculture and the opioid epidemic.

The basic requirements of the systems to be developed include high-throughput transaction processing, traceability or tracking, visibility or monitoring, and transparency throughout the supply and value chains for the stakeholders. The development of this architecture will serve as an online commercial portal to service Pacific Software’s B2B accounts in the sectors below.

For application of its Agri-blockchain based system, Pacific Software will target farm-to-consumer exports to increase transparency, combat theft and counterfeit products, and reduce the health risks associated with shipping “tainted” agricultural products to other countries.

Controlled Substances
With the misuse of opioids on the rise worldwide, Pacific Software aims to apply its blockchain-based system to track opioids from pharmaceutical production to consumers and attempt to identify “Bad Actors” in the supply chain and fight against the global epidemic.

Business Model
The portal will be structured in a B2B format where clients will pay the company transaction fees, royalties, cash, cash equivalents and other forms of compensation to utilize its Hyperledger blockchain applications for their business models.

As the company executes these strategies, each Hyperledger blockchain-based system designed may be organized separately in wholly owned subsidiaries. To enhance its portfolio of holdings, Pacific Software may consider investments in companies where selected markets have imminent profitable results, providing appreciable value for investors and shareholders.

Pacific Software, Inc. (PFSF), closed the day's trading session at $5.50, even for the day. The average volume for the last 3 months is 61 and the stock's 52-week low/high is $3.50/$5.50.

Recent News


Kontrol Energy Corp. (CSE: KNR) (FSE: 1K8)

The QualityStocks Daily Newsletter would like to spotlight Kontrol Energy Corp. (CSE: KNR).

Kontrol Energy (CSE: KNR) (FSE: 1K8) is offering investors budding growth opportunities with its methodical mergers and acquisition (“M&A”) strategy in tandem with organic growth. To view the full article, visit:

Kontrol Energy Corp. (CSE: KNR) (FSE: 1K8) specializes in the integration of smart energy technologies and solutions for North American commercial and industrial property owners and operators to help them benefit from energy cost savings and minimize greenhouse gas emissions. Kontrol is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology and is ranked by Canadian Business and Maclean’s as the 7th fastest growing startup in 2018.

Kontrol’s leadership position is reshaping the way customers use, manage and strategically allocate energy resources to realize immediate energy savings by gaining more control over energy consumption and demand in real-time.

As the fastest growing global “fuel source,” energy efficiency is big business with industry analysts noting this multi-trillion-dollar market offers significant opportunities over the next five years. Established market segments include: energy retrofits ($71.4 billion); distributed generation ($179.9 billion); energy analytics ($33.5 billion); and greenhouse gas/carbon measurement, reduction ($1.2 trillion). Each $1 invested in energy efficiency displaces up to $3 of utility-scale transmission and distribution investment, according to the International Energy Agency.

Formed in 2015 by a group of energy veterans who recognized that the energy efficiency industry is one of the fastest growing fuel sources for the global economy, Kontrol is committed to enhancing and improving its customers sustainability objectives. In less than two years, Kontrol has grown its revenue run rate to $16 million from $1.8 million, delivering on stated goals and objectives as it seeks to continue this pattern through accretive acquisitions and the expansion of the company’s smart energy technologies.

Up to 50 percent of Kontrol’s overall revenues are recurring annually, and the company’s 2019 outlook includes strategic initiatives that will expand the company’s smart energy technologies to U.S. markets, bring additional accretive and strategic acquisitions, and accelerate recurring SaaS revenues.

Kontrol’s strategy of disciplined mergers and acquisitions includes the following highlights:

  • Acquisition of Log-One Ltd.’s award-winning energy conservation technology, Energy Management System (“EMS”), an intelligent, occupancy-based heating and air-conditioning control system for commercial and multi-residential real estate. Rebranded as Kontrol EMS Technology, the company has added IoT and mobile application capabilities, creating a recurring revenue platform through a Software-as-a-Service (SaaS) platform.
  • Acquisition of ORTECH Consulting Inc., an engineering consulting firm specializing in Greenhouse Gas (GHG) reporting, emission testing, air quality testing and renewable energy/power consulting.
  • Acquisition of Efficiency Engineering Inc. (“EE Inc.”), which provides engineering services to industrial, municipal and commercial building owners across Canada. EE Inc. provides detailed energy efficiency analysis, energy audits, management of facility system solutions, electrical and mechanical design and energy conservation studies.
  • Acquisition of MCW Dimax Ltd. (“MCX”), a firm specializing in solutions for the application of energy software to analyze the management of complex heating, ventilation and cooling systems for large residential, commercial, and mission critical real estate owners.
  • Acquisition of CEM Specialties Inc. (“CEMSI”), a market leader in turn-key emission monitoring, equipment and solutions.

The company has also established entry into the North American cannabis market as a supplier of integrated energy efficiency solutions and technologies. Within this market, Kontrol is focused on assisting cannabis growers to reduce the cost of energy and support mission critical infrastructures. To date, Kontrol has secured two contracts to provide energy efficiency services with Licensed Producers in the Canadian cannabis sector.

The Kontrol Energy group of companies is currently saving its customers more than 40 million kilowatt hours of electricity per annum and providing a corresponding reduction in GHG emissions.

Kontrol’s management team includes CEO Paul Ghezzi, a leader in clean tech, renewable energy development, solar project financing and distributed generation. Ghezzi has global experience in power generation projects under Feed-in Tariff programs and Power Purchase Agreement programs for both commercial and utility-scale projects. COO Kristian Lavereau has more than 25 years of experience in the IT solutions (analytics and mobile computing), energy optimization and efficiency (intelligent control systems, solar PV, lighting). Claudio Del Vasto, CPA, CA | CFO, is a senior finance executive with an extensive background in corporate finance, strategy and business development.

Kontrol Energy Corp. (CSE: KNR), closed the day's trading session at $0.63, off by 1.56%, on 1,000 volume with 2 trades. The average volume for the last 3 months is 19,823 and the stock's 52-week low/high is $0.46/$1.58.

Recent News


Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4)

The QualityStocks Daily Newsletter would like to spotlight Redfund Capital Corp. (PNNRF).

Recent developments in regulation and research and development in the cannabis space are set to swell the project pipeline of Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4). In November, a government committee in Israel approved the first draft of a law on the export of medical cannabis, a move welcomed by the industry, with one commentator ( opining, “Although a small step in the dry process of legislation, it’s a huge leap forward for the industry.” Medical cannabis has been domestically available in Israel for at least two decades. Its export, however, has been prohibited, leaving untapped, some say, a market worth around $4 billion.

Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4) is a merchant bank focused on providing debt and equity funding in the mid to late stages of a target company’s development and for technologies that are developed and validated by revenues. Redfund’s current focus is on medical cannabis, hemp and cannabidiol (CBD) related and healthcare-related companies.

As the first medical cannabis incubator and accelerator financing medical cannabis, CBD and hemp companies through a debt facility, Redfund is effectively bridging finance gaps and helping revenue-producing medical cannabis-related companies grow and build their valuations without prematurely diluting their equity.

The central components of the company’s business strategy are:

  • Establishing the foundation of a loan portfolio that generates revenues through monthly interest income from loans to cover all general and administrative expenses related to day-to-day operations.
  • Growing shareholder value by converting all or part of loans and warrants into equity in portfolio clients as clients build their valuations by entering the public markets or becoming the high-priced targets of larger entities.

Redfund was designed by bankers and entrepreneurs possessing years of experience in business, consulting, capital markets, corporate finance and healthcare services. The company is actively looking beyond borders and creating global companies that have strong fundamentals and are ready to expand.

Redfund’s investments are deployed to companies that have demonstrated success in their business but need a capital bridge in order to expand. Redfund’s team of professionals vet every project and analyzes each prospective client’s financials and business plans. Once a project is approved, Redfund’s legal team carefully scrutinizes the collateral used to securitize the individual loans.

The strategy employed by Redfund includes:

  • Diversifying investments in Canada and other countries
  • Building an international footprint with established national leaders
  • Funding new drug delivery systems and helping nutraceuticals become mainstream drugs
  • Introducing companies to Canada as a viable option for public listings
  • Becoming a premier go-to lender for established companies

The company’s revenue sources include:

  • Interest-bearing debt instruments with asset-backed collateral to securitize loans
  • Equity kicker of warrants coverage on original loan
  • Conversion ability of loan in its entirety
  • Advisory fees from contracts for consulting on growth strategies
  • Right of first refusal on future financing in each company funded

Redfund Capital Corp. (PNNRF), closed the day's trading session at $0.279, even for the day. The average volume for the last 3 months is 370 and the stock's 52-week low/high is $0.244/$0.505.

Recent News


Spectrum Global Solutions, Inc. (SGSI)

The QualityStocks Daily Newsletter would like to spotlight Spectrum Global Solutions, Inc. (SGSI).

The ever upward-spiraling hunger that consumers feel for mobile computer data delivery is fueling the next surge in transmission power as 5G networks begin making inroads throughout the developed world’s communications infrastructure, and Spectrum Global Solutions, Inc. (OTC: SGSI) is poised to play a key role in delivering and maintaining that infrastructure.

Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:

  • AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
  • ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
  • Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.

Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.

Market Opportunity

Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.


CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.

Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.

Spectrum Global Solutions, Inc. (SGSI), closed the day's trading session at $0.12, off by 29.41%, on 10,013 volume with 8 trades. The average volume for the last 3 months is 20,312 and the stock's 52-week low/high is $0.116/$2.59.

Recent News


FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF)

The QualityStocks Daily Newsletter would like to spotlight FinCanna Capital Corp. (FNNZF).

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, is pleased to announce that its investee company Refined Resin Technologies Inc. (“Refined Resin”) of Oakland, California, has been issued its California state, “Adult-Use and Medicinal – Temporary Distributor License” (“Temporary Distributor License”). Refined Resin is a cannabinoid research and extraction company that provides B2B products and services to licensed dispensaries, licensed infused product manufacturers and licensed distributors in the medical cannabis supply chain.

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages extensive investment expertise and industry experience to benefit its shareholders and portfolio companies.

Medical Cannabis Market

According to Ameri Research, the global market for licensed medical cannabis is growing at a compound annual growth rate (CAGR) of more than 21%, on track to exceed $63.5 billion by 2024. Within this market, FinCanna has identified considerable opportunity in California, the fifth largest economy in the world and the largest medical cannabis market in North America. Arcview Group forecasts California’s legal cannabis industry will grow at 21.1% CAGR to $6.5 billion in 2020, generating more than $1 billion in tax revenue.

Royalty Model & Portfolio

FinCanna’s “whole capital” solution for businesses in the licensed medical cannabis sector includes the provision of capital investment for a percentage of their future revenues. The FinCanna Capital Solution utilizes a royalty arrangement to deliver capital, in order to facilitate the growth or other specific objectives of its investees, and ensure the business opportunity is optimized. This model provides an alternative or complement to debt and equity financing, allowing investees to maintain financial flexibility and control of their business rather than entering into arrangements that may include restrictive debt structures or giving up an ownership stake.

FinCanna’s portfolio includes Cultivation Technologies, Inc. (“CTI”), a team of experts from Fortune 150 agriculture, medical cannabis, law, engineering and technology companies. FinCanna is providing funding to CTI for its planned, fully entitled, large-scale indoor medical cannabis facility to be developed in Coachella, California.

CTI has established an interim medical cannabis extraction facility (the “Interim Facility”) that will produce licensed medical cannabis products until the Coachella Project is complete. CTI is currently expanding its product line, Coachella Premium, to include vaporizer cartridges. Initial market feedback gathered during the product development phase indicates that Coachella Premium’s vaporizer cartridges offer a unique proposition within the vaporizer market, one of the fastest growing verticals in the cannabis market.

The Interim Facility can process up to 6,000 pounds of biomass per month, the equivalent of approximately 3.7 million grams of raw oil per year, with room for expansion. It is expected that the completed Coachella Project will be able to process 30,000 to 50,000 pounds of biomass per month, or the equivalent of 18 million grams to 30 million grams of raw oil per year.

Additionally FinCanna has entered into a royalty agreement with Green Compliance, a provider of point-of-sale software solution (“ezGreen”) for licensed medical cannabis dispensaries and cultivators. Green Compliance helps its customers comply with both the Health Insurance Portability and Accountability Act (“HIPAA”) and State Laws by ensuring patients’ confidential data is being handled properly, helping to protect from possible security breaches and financial and criminal liability resulting from potential violations.

FinCanna has also signed binding term sheet with Oakland, California-based Gram Co Holdings, subject to due diligence by FinCanna. Gram Co is a cannabinoid research and refinement facility focused providing B2B and B2C products and services to licensed medical dispensaries, infused product manufacturers, and numerous others in the cannabis supply chain. The company is also retrofitting a large, state-of-the-art medical cannabis extraction laboratory, which is expected to be operating in 2018.

The foregoing contains forward-looking statements regarding Cultivation Technologies Inc. (“CTI”) which are subject to risks, uncertainties and contingencies which include, but are not limited to the statements relating the future construction and completion of the CTI medical cannabis facility in Coachella, California, and the projected biomass processing and raw oil production at the facility. Such forward looking statements are based on assumptions regarding the construction, completion and operations of CTI’s proposed facility, including that CTI will obtain the financing required to build and equip its proposed facility, that CTI will obtain the additional financing required operate the facility, that construction facility is completed on time and budget, that CTI obtains state licenses to operate on a permanent basis, and that the equipment used in the cultivation of medical cannabis performs at scale in a similar way it performs at CTI’s pilot tests.

FinCanna Capital Corp. (FNNZF), closed the day's trading session at $0.0784, even for the day, on 2 volume with 2 trades. The average volume for the last 3 months is 53,406 and the stock's 52-week low/high is $0.0577/$0.8736.

Recent News


Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF)

The QualityStocks Daily Newsletter would like to spotlight Therma Bright, Inc. (OTC: THRBF).

Medical device technology provider Therma Bright (TSX.V: THRM) (OTC: THRBF) is focused on serving the cosmeceutical industry through its innovative products, devices and treatments that address dermatological needs. To view the full article, visit:

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) is a medical device technology provider focused on addressing dermatological needs in the multi-billion-dollar cosmeceutical industry. The company’s effective, non-invasive and pain-free skin care is based on proprietary technology which has received Class II medical device status from the U.S. Food and Drug Administration.

Therma Bright’s portfolio includes products, devices and treatments that have both cosmetic and medicinal or therapeutic benefits, such as for relief of pain, itch and inflammation resulting from more than 20,000 types of insect and marine life bites and stings, including bees, wasps, hornets, mosquitos, black flies and jellyfish.

The Company’s current focus is to market its products online through various social media networks, and to eventually re-establish relationships with major North American and Global retailers.


The company currently has two products on the market and another in the research and development phase:

InterceptCS™ is a thermal therapy device for the treatment and prevention of cold sores caused by the herpes simplex Type 1 virus*. Symptoms typically include sores around the mouth and lips which InterceptCS™ treats by application of controlled topical heat with no risk of burning the skin. When used at the first sign of an oncoming cold sore application of InterceptCS™ can prevent symptoms from developing. Infrared energy and light from the device penetrate the skin killing cells infected with the virus.

InterceptCS™ is available without prescription and comprises a battery powered ergonomic hand-held unit and a disposable single-use treatment activator. Therma Bright has completed prototyping of multi-use activators for InterceptCS™. The company plans to bring to market 5, 10 or 20 multi-use activations at prices that will offer customers greater value than the current single-use activator.

The other Therma Bright product currently under development is TherOZap™, a next generation thermal therapy device powered by the company’s core technology, which is approved by the FDA as a Class II medical device for the relief of the symptoms of insect bites. Therma Bright is testing a new easier-to-use prototype of the device for effectiveness against Zika virus and other diseases carried by mosquitos. Once the technology proves effective, Therma Bright intends to seek regulatory approvals and extend the prototype enhancements to a new commercial version of TherOZap™.


Therma Bright is also conducting research and development on a unique thermal therapy device that would incorporate medical grade cannabis or cannabidiol (“CDB”) sourced from hemp as a cream or gel to provide relief of back, knee and other joint pain. In preparation, the company has incorporated a wholly owned subsidiary to hold any technology for use or application of cannabis. Once approvals are secured, the company plans to sell the device through licensed cannabis producers or retailers across Canada and in international markets where use of cannabis has been legalized. The company has initiated trademark and patent protection for its thermal therapy technology incorporating medical cannabis. Therma Bright has indicated it will seek an acquisition to help further development of this product.

Market Opportunity

A report by market intelligence firm Mordor Intelligence put the global cosmeceuticals market at a value of nearly US$47 billion in 2017 and projects it to be worth more than $80 billion by 2023, growing at a rate of almost 9.5 percent annually. Medical research estimates that somewhere between 20 percent and 40 percent of the population suffer occasional cold sore outbreaks. In Canada those figures would mean five to 10 million people, and in the U.S. some 40 million to 80 million, with recurring cold sores, representing a substantial potential market for Therma Bright.


Rob Fia serves as Therma Bright chairman and CEO. Fia has extensive contacts in the investment community and the financial sector as well as knowledge of various Canadian stock exchange listing processes and requirements. His 18 years in the investment business has included equity research and advising promising early stage companies on corporate finance. Therma Bright CFO Victor Hugo is a senior financial analyst at Marrelli Support Services Inc., for which he provides CFO, accounting, regulatory compliance, and management advisory services to companies listed on the TSX, TSX Venture Exchange and other Canadian and US exchanges.

**Based on double blind placebo study, the InterceptCS™ is approved by Health Canada for the claim “For prevention of cold sores when used within 3 hours of the onset of the prodrome.” The InterceptCS™ is not approved by the United States FDA or any claim of clinical indication, clinical efficacy, and/or cure or prevention of disease.

Therma Bright, Inc. (OTC: THRBF), closed the day's trading session at $0.0099, even for the day. The average volume for the last 3 months is 436 and the stock's 52-week low/high is $0.0099/$0.0289.

Recent News


The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings Ltd. (TSX : TGOD) (US : TGODF) is pleased to announce it has signed a royalty-bearing commercial sublicense (the "Agreement") with EnWave Corporation (TSX-V:ENW | FSE:E4U) ("EnWave") and Tilray, Inc. (NASDAQ:TLRY) ("Tilray").

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $1.93, off by 1.53%, on 1,000,752 volume with 1,300 trades. The average volume for the last 3 months is 1,035,000 and the stock's 52-week low/high is $1.607/$7.894.

Recent News



The QualityStocks Daily Newsletter would like to spotlight GTX Corp (GTXO).

GTX Corp (OTCQB: GTXO) (“the Company”), a pioneer in the field of wearable GPS human and asset tracking systems and wandering assistive technology, today announced securing a revolving line of credit for production financing, and onboarding two new distributors, one in Canada and the other in the U.S.

GTX Corp (GTXO), a For Profit For Purpose company, designs, manufactures and commercializes various products and services in the GPS tracking and monitoring business.  Operating domestically and internationally, via two subsidiaries engaged in the internet of things (IoT) and wearable technology industry. Founded in 2002 and headquartered in Los Angeles, California, the company is a pioneer in Smart GPS, cellular and Bluetooth Low Energy (BLE) tracking technology, offering complete, end-to-end tracking solutions through a proprietary IoT enterprise monitoring platform – the IoT Machine to Machine platform – backed by state-of-the-art hardware, software and connectivity solutions, patents and software algorithms.

Operating under the motto “We Put the ‘Where’ in Wearable Tech,” GTX’s main goal is to keep its customers connected to who and what matters most, with each of its patented tracking technologies providing real-time location coordinates on a map via a personalized portal. The company prides itself on offering not only technologies, but also effective solutions that provide safety, security and peace of mind by helping customers locate their loved ones or lost valuable items.

With a portfolio that includes more than 80 patents filed and issued and with products and services available in 35 countries, GTX’s tracking solutions use the latest in miniaturized, low-power GPS, mobile, RF and BLE technology, that can integrate seamlessly with multiple consumer products, enterprise and military applications. The company became a U.S. Military contractor in 2017 and is already developing asset and human tracking technology for the U.S. Air Force. Its list of customers also includes public health authorities and municipalities, emergency and law enforcement, NGOs, private companies, public and private senior care homes, and consumers.

The company’s flagship product is the award-winning GPS SmartSole®, the world’s first invisible wearable tracking device created specifically for people at risk of wandering, becoming lost or disoriented, including patients with Alzheimer’s, autism, dementia, traumatic brain injury and other cognitive problems. According to the World Alzheimer Report 2013 (, there are more than 100 million people worldwide who need constant care and monitoring because of a cognitive disorder, and their number is expected to rise to 277 million by 2050. Due to its hidden location – inside a shoe insert, the device can also be used by people undercover or at risk of kidnapping, such as government agents, military personnel, law enforcement, journalists, corporate executives, etc.

Other tracking devices designed and commercialized by the company for civilian or military use include:

  • Take-Along Tracker 3G: A powerful mini-tracking device with GPS, 2G and 3G GSM data and voice capabilities, as well as a motion sensor and sleep mode. The device can be easily attached to a keychain, lanyard, dog collar, pocket, bag or plush toy for a discreet but advanced tracking solution.
  • Invisabelt: Designed for children, this slim GPS tracker hidden inside a small waistband belt has a battery life of up to two days and is a great solution for parents who want to monitor their children’s location at all times.
  • Track My Workforce: An easy and cost-effective solution that allows businesses to track and monitor their mobile workforce. The app is available for both Android and iOS systems, and allows employers to monitor their workforce from a single company account.
  • P.E.T.S. -Personnel Equipment Tracking System: Currently in use at the Edwards Air Force Base, this tracking system allows real-time monitoring and surveillance of personnel and assets and has a 200+ square mile coverage. Solar powering capabilities and extend battery life allow the tracker to be used in areas without existing power sources.
  • GPS Rifle Tracker: The company’s smallest GPS tracker, designed to withstand shocks and water submersion due to its robust, military standard enclosure, can be mounted on any AR15 platform picatinny rail to detect weapon discharge, track weapons and inventory, and send time and location alerts.

Led by a management team with solid experience in wearable technology, IoT, consumer electronics, mobile and technology licensing, as well as finance and the footwear industry, GTX plans to leverage its core technology platform to reach new verticals via licensing agreements and strategic partnerships, and to monetize its intellectual property portfolio. The monetization campaign kicked off in 2017 has already identified 100 companies that could become licensees. Besides military and law enforcement, the company also eyes the biometrics market, home health, medicare and insurance and other security applications for potential uses of its IoT platform and tracking technology.

GTX currently has 15 domestic and international distributors, subscribers in 35 countries and more than 700 online affiliates. With multiple revenue streams, several consecutive years of double-digit revenue growth and a strong pipeline of lucrative commercial products, GTX is uniquely positioned to become a leading provider of tracking solutions on this growing multi-billion-dollar market.

GTX Corp (GTXO), closed the day's trading session at $0.00871, off by 3.22%, on 341,534 volume with 23 trades. The average volume for the last 3 months is 174,869 and the stock's 52-week low/high is $0.0061/$0.449.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.